SEARCH RESULT

Total Matching Records found : 646

Armed with whistle-blower policy, Ranbaxy to look ahead-Sushmi Dey

-The Business Standard Patient safety & quality our guidance now, says Sawhney Trouble-hit Ranbaxy Laboratories has introduced a whistle-blower policy within the company to encourage transparency and address concerns internally, so that bigger problems could be averted. In his first interaction with the media (the first part of which was published on Sunday) since the drug maker pleaded guilty of making Fraudulent statements to the US Food and Drugs Administration (FDA) under its...

More »

Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, interviewed by The Economic Times

-The Economic Times Indian pharmaceutical company Ranbaxy recently paid $500 million to the US government to settle civil and criminal charges for making Fraudulent statements to the US FDA and selling adulterated drugs in the US. Dinesh Thakur, an ex-Ranbaxy employee who blew the whistle on the company, talks to ET about the five-year long investigation and the future of generic drug companies in the US. Edited Excerpts: * You think you...

More »

Ponzi scam: Over 150 petitions found on rail track

-PTI Burdwan (WB): About 150 sheets, allegedly copies of petitions filed by depositors related to the Saradha chit fund scam, were found on the side of rail tracks between Kalna and Guptipara stations of Eastern Railway's Howrah-Burdwan section on Sunday. GRP sources said about 150 papers, claimed to be petitions of depositors from Murshidabad and Jharkhand, were spotted ying on the sides of the rail track at Purbo Satgachia station by local...

More »

A deception most foul-Narayan Lakshman

-The Hindu   Ranbaxy's Fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its Fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...

More »

Aadhaar triple booster-Sobhana K

-The Telegraph The Unique Identification Authority of India (UIDAI) today unveiled three services that will help people authenticate their identity anytime, anywhere by just using their Aadhaar number instead of the card. The iris-based authentication, OTP (one-time password) and e-KYC (know your customer) services will ensure Aadhaar cardholders don't have to carry address or identity proofs to get a phone or cooking gas connection. Service providers like banks or telecom firms merely...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close